Skip to content
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Image: Shutterstock/Andreas Prott

Oxford/AstraZeneca Covid-19 vaccine applies for EU approval

A decision on its authorisation could be reached later this month.
Jan 12th 2021, 8:56 AM 23,149 50

THE EUROPEAN MEDICINES Agency (EMA) has received an application for approval of the Oxford/AstraZeneca Covid-19 vaccine.

A decision on the conditional marketing authorisation of the vaccine could be issued by 29 January, the EMA said. 

The assessment of the vaccine will proceed under an accelerated timeline. If approved, it would be the third Covid-19 vaccine given the green light in the EU after Pfizer/BioNTech and Moderna. 

A conditional marketing authorisation results in a fast-tracked approval during public health emergencies valid throughout all EU member states. 

European Commission President Ursula von der Leyen described this as “good news” on Twitter. 

“Once the vaccine receives a positive scientific opinion, we will work full speed to authorise its use in Europe,” she said. 

The Oxford/AstraZeneca vaccine was approved for use in the UK late last month. 

This speedy evaluation process is possible because the EMA has already reviewed some data on the vaccine during a rolling review. 

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

Send a tip to the author

Orla Dwyer

COMMENTS (50)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a comment

     
    cancel reply
    Back to top